HomepageAMBBY • OTCMKTS
add
Ambu
Vorige slotkoers
$ 16,69
Dag-range
$ 17,57 - $ 17,57
Jaar-range
$ 13,02 - $ 22,65
Beurswaarde
32,33 mld. DKK
Gem. volume
97,00
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,51 mld. | 20,41% |
Bedrijfskosten | 682,00 mln. | 11,26% |
Netto inkomsten | 183,00 mln. | 98,91% |
Netto winstmarge | 12,12 | 65,12% |
Winst per aandeel | 0,68 | 94,29% |
EBITDA | 331,00 mln. | 55,40% |
Effectief belastingtarief | 22,78% | — |
Balans
Totale activa
Totale passiva
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 588,00 mln. | 112,27% |
Totale activa | 7,38 mld. | 7,93% |
Totale passiva | 1,58 mld. | 11,86% |
Totaal aandelenvermogen | 5,80 mld. | — |
Uitstaande aandelen | 266,39 mln. | — |
Koers-boekwaardeverhouding | 0,77 | — |
Rendement op activa | 8,36% | — |
Rendement op kapitaal | 9,71% | — |
Kasstroom
Nettomutatie in liquide middelen
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 183,00 mln. | 98,91% |
Operationele kasstroom | 144,00 mln. | -23,81% |
Kasstroom uit beleggingen | -75,00 mln. | -38,89% |
Kasstroom uit financiering | -97,00 mln. | -546,67% |
Nettomutatie in liquide middelen | -27,00 mln. | -122,50% |
Vrije kasstroom | -17,38 mln. | -112,49% |
Over
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services.
It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.
The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
Opgericht
1937
Website
Werknemers
5.000
